| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
ABBV
AbbVie
|
Oct 29, 2026 | BUY |
Strong Buy
-14.5% avg upside
47 analysts
|
$279.00
5.32% Downside
|
+1.5% | · |
|
ORKA
Oruka Therapeutics
|
Oct 27, 2026 | BUY |
Strong Buy
+37.2% avg upside
16 analysts
|
— | +9.7% | · |
|
VRTX
Vertex Pharmaceuticals
|
Oct 27, 2026 | BUY |
Strong Buy
-20.5% avg upside
62 analysts
|
— | +3.4% | · |
|
JNJ
Johnson & Johnson
|
Oct 27, 2026 | BUY |
Strong Buy
-9.1% avg upside
40 analysts
|
$272.00
0.34% Downside
|
+5.5% | · |
|
LLY
Eli Lilly & Co
|
Oct 21, 2026 | BUY |
Strong Buy
-16.7% avg upside
50 analysts
|
$1316.00
7.20% Downside
|
+12.3% | · |
|
ANAB
AnaptysBio
|
Oct 21, 2026 | BUY |
Strong Buy
+48.7% avg upside
26 analysts
|
$81.00
67.82% Upside
|
-3.5% | · |
|
REGN
Regeneron
|
Oct 21, 2026 | HOLD |
Strong Buy
-12.1% avg upside
60 analysts
|
$835.00
10.07% Downside
|
+18.6% | · |
|
TRAX
First Tracks Biotherapeutics Inc
|
Oct 19, 2026 | BUY |
Strong Buy
+64.6% avg upside
11 analysts
|
$90.00
99.64% Upside
|
+29.8% | · |
|
TECX
Tectonic Therapeutic
|
Oct 15, 2026 | BUY |
Strong Buy
+176.5% avg upside
24 analysts
|
$60.00
203.33% Upside
|
-0.8% | · |
|
TENX
Tenax Therapeutics
|
Oct 09, 2026 | BUY |
Buy
+1239.2% avg upside
9 analysts
|
$4.00
123.41% Upside
|
-4.8% | · |
|
BMY
Bristol-Myers Squibb
|
Oct 07, 2026 | HOLD |
Buy
-2.2% avg upside
42 analysts
|
$59.00
5.62% Downside
|
+4.3% | · |
|
HALO
Halozyme
|
Oct 07, 2026 | BUY |
Strong Buy
-48.1% avg upside
20 analysts
|
$110.00
16.06% Downside
|
-9.5% | · |
|
ENTX
Entera Bio
|
Sep 18, 2026 | BUY |
Strong Buy
+156.2% avg upside
6 analysts
|
$9.00
181.25% Upside
|
+5.1% | · |
|
SCTX
Scribe Therapeutics Inc.
|
Aug 18, 2026 | BUY |
Strong Buy
+235.6% avg upside
4 analysts
|
$37.00
139.95% Upside
|
-42.1% | · |
|
IMA
ImageneBio
|
May 08, 2026 | BUY |
Strong Buy
+336.6% avg upside
13 analysts
|
$24.00
485.37% Upside
|
-32.3% | · |
|
AMGN
Amgen
|
Jan 13, 2026 | HOLD |
Buy
-29.9% avg upside
57 analysts
|
— | +47.0% | · |
|
FR:SAN
Sanofi
|
Dec 24, 2025 | BUY |
Strong Buy
+21.3% avg upside
30 analysts
|
— | +7.5% | · |
|
ROIV
Roivant Sciences
|
Dec 15, 2025 | BUY |
Strong Buy
+10.7% avg upside
19 analysts
|
$32.00
13.33% Downside
|
+80.5% | · |
|
PFE
Pfizer
|
Dec 09, 2025 | HOLD |
Buy
+9.2% avg upside
46 analysts
|
$26.00
14.82% Downside
|
+21.7% | · |
|
PCVX
Vaxcyte
|
Oct 01, 2025 | BUY |
Strong Buy
+77.8% avg upside
15 analysts
|
— | +47.4% | · |
|
SNY
Sanofi
|
Sep 04, 2025 | BUY |
Strong Buy
+64.5% avg upside
20 analysts
|
— | +3.0% | · |
|
SVRN
OceanPal Inc
|
Aug 17, 2025 | BUY |
Strong Buy
6 analysts
|
— | -84.9% | · |
|
GPCR
Structure Therapeutics, Inc. Sponsored ADR
|
Aug 07, 2025 | BUY |
Strong Buy
+373.3% avg upside
17 analysts
|
$44.00
101.12% Upside
|
+228.0% | · |
|
MRNA
Moderna
|
Apr 16, 2025 | SELL |
Hold
-48.5% avg upside
38 analysts
|
$23.00
89.63% Downside
|
-117.1% | · |
|
MP
MP Materials
|
Feb 24, 2025 | BUY |
Strong Buy
+60.9% avg upside
23 analysts
|
$28.00
29.21% Downside
|
+140.8% | · |
|
IRWD
Ironwood Pharma
|
Jan 17, 2025 | HOLD |
Hold
+239.4% avg upside
23 analysts
|
— | +22.9% | · |
|
CABO
Cable ONE
|
May 01, 2024 | BUY |
Hold
+10693.7% avg upside
9 analysts
|
— | -31.7% | · |
|
GILD
Gilead Sciences
|
Apr 28, 2023 | HOLD |
Strong Buy
-27.3% avg upside
66 analysts
|
$91.00
46.64% Downside
|
-17.3% | · |
|
PAX
Patria Investments
|
Mar 14, 2023 | BUY |
Hold
+50.0% avg upside
7 analysts
|
— | -1.2% | · |
|
OGN
Organon
|
Jun 11, 2021 | HOLD |
Sell
+7.4% avg upside
9 analysts
|
$33.00
138.51% Upside
|
+23.6% | · |
|
JAZZ
Jazz Pharmaceuticals
|
May 21, 2021 | HOLD |
Strong Buy
+16.2% avg upside
36 analysts
|
$176.00
18.56% Downside
|
-17.5% | · |
|
PAHC
Phibro Animal Health
|
May 13, 2021 | SELL |
Sell
+0.0% avg upside
10 analysts
|
$22.00
43.48% Downside
|
+31.4% | · |
|
MRK
Merck & Company
|
Apr 01, 2021 | BUY |
Strong Buy
-3.5% avg upside
44 analysts
|
$90.00
39.76% Downside
|
+17.7% | · |
|
VTRS
Viatris
|
Mar 10, 2021 | HOLD |
Buy
+25.5% avg upside
22 analysts
|
$16.00
15.90% Downside
|
-25.7% | · |
|
PRGO
Perrigo Company
|
Mar 05, 2021 | HOLD |
Buy
+333.3% avg upside
20 analysts
|
$45.00
185.14% Upside
|
-6.4% | · |
|
TSE:BHC
Bausch Health Companies
|
Feb 26, 2021 | HOLD |
Buy
+386.9% avg upside
30 analysts
|
$48.91
326.43% Upside
|
-22.8% | · |
|
ALKS
Alkermes
|
Dec 21, 2020 | HOLD |
Buy
-3.4% avg upside
34 analysts
|
$22.00
51.54% Downside
|
+8.1% | · |
|
ELAN
Elanco Animal Health
|
Nov 23, 2020 | BUY |
Strong Buy
+35.1% avg upside
20 analysts
|
$41.00
77.84% Upside
|
+3.4% | · |
|
ZTS
Zoetis
|
Nov 13, 2020 | HOLD |
Buy
+43.7% avg upside
25 analysts
|
$174.00
118.17% Upside
|
+30.8% | · |
|
RPRX
Royalty Pharma
|
Jul 13, 2020 | HOLD |
Strong Buy
-12.2% avg upside
15 analysts
|
$51.00
24.12% Downside
|
-5.2% | · |
|
AMRX
Amneal Pharmaceuticals
|
Apr 02, 2020 | HOLD |
Strong Buy
-10.1% avg upside
19 analysts
|
$3.00
86.03% Downside
|
+116.4% | · |
|
COR
Cencora
|
Nov 16, 2015 | HOLD |
Strong Buy
-2.6% avg upside
45 analysts
|
— | -17.9% | · |
|
ORCL
Oracle
|
Sep 21, 2012 | BUY |
Strong Buy
+65.3% avg upside
71 analysts
|
$36.00
72.48% Downside
|
+6.0% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.